BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20163841)

  • 1. Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein.
    Woldu SL; Barlow LJ; Patel T; Hruby GW; Benson MC; McKiernan JM
    Urology; 2010 Sep; 76(3):639-42. PubMed ID: 20163841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial nephrectomy in two patients with known T3a tumours involving the renal vein.
    Kim EH; Jain S; Benway BM; Figenshau RS
    BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephron-sparing surgery for pathological stage T3b renal cell carcinoma confined to the renal vein.
    Kolla SB; Ercole C; Spiess PE; Pow-Sang JM; Sexton WJ
    BJU Int; 2010 Nov; 106(10):1494-8. PubMed ID: 20230378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
    BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
    Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
    BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nephron-sparing surgery for localized kidney neoplasms--a report of 25 cases].
    Li YH; Zhou FJ; Qin ZK; Han H; Liu ZW; Wang B; Yu SL; Wang H
    Ai Zheng; 2006 Jan; 25(1):76-9. PubMed ID: 16405755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M; Thibault GP; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of stage pT3b renal cell carcinoma in solitary kidneys: a case series.
    Sengupta S; Zincke H; Leibovich BC; Blute ML
    BJU Int; 2005 Jul; 96(1):54-7. PubMed ID: 15963120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of mini-margin nephron-sparing surgery for renal cell carcinoma 4-cm or less.
    Li QL; Cheng L; Guan HW; Zhang Y; Wang FP; Song XS
    Urology; 2008 May; 71(5):924-7. PubMed ID: 18267335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term outcomes of mini-margin nephron sparing surgery for renal cell carcinoma].
    Li QL; Guan HW; Song XS; Wu HC
    Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(4):286-8. PubMed ID: 18683767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Marechal JM; Klotz L; Skinner E; Keane T; Claessens I; Sylvester R; ; ; ;
    Eur Urol; 2007 Jun; 51(6):1606-15. PubMed ID: 17140723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.
    Lambert EH; Pierorazio PM; Shabsigh A; Olsson CA; Benson MC; McKiernan JM
    Urology; 2007 Jun; 69(6):1054-8. PubMed ID: 17572185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
    Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
    Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
    Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
    Minervini A; Serni S; Giubilei G; Lanzi F; Vittori G; Lapini A; Carini M
    Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine frozen-section biopsy from the surgical bed should be performed during nephron-sparing surgery for renal cell carcinoma.
    Eroğlu M; Unsal A; Bakirtaş H; Tekdoğan U; Ataoğlu O; Balbay MD
    Scand J Urol Nephrol; 2005; 39(3):222-5. PubMed ID: 16118094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.